Search results
Showing 5641 to 5655 of 7679 results
Recommendation ID NG20/5 Question Frequency of monitoring:- What is the effectiveness of more frequent monitoring compared with monitoring
Recommendation ID NG82/4 Question Frequency of monitoring:- What is the long-term cost effectiveness, in terms of patient-relevant outcomes
Recommendation ID NG203/12 Question Frequency of review: What is the most clinical and cost-effective frequency of review for children
Recommendation ID NG24/4 Question Fresh frozen plasma for patients with abnormal haemostasis who are having invasive procedures or surgery:-
Recommendation ID NG216/01 Question Needs assessment: From the perspective of everyone involved, what is the acceptability of strengths
Recommendation ID IPG725/02 Question For people with favourable aneurysm morphology needing an EVAR as a primary procedure, evidence on
Recommendation ID CG115/6 Question For people with alcohol dependence, which medication is most likely to improve adherence and thereby
Recommendation ID CG113/3 Question For people with generalised anxiety disorder (GAD) who are ready to start a low-intensity intervention
Recommendation ID NG203/19 Question Antiplatelet therapy: For people with CKD at the highest risk of cardiovascular disease, what is the
Recommendation ID NG230/06 Question Thyroid peroxidase antibody testing: For people with indeterminate cytopathology, what is the clinical
Recommendation ID NG14/08 Question Surgical excision for people with lentigo maligna: For people with lentigo maligna (stage 0 in sun damaged
Recommendation ID IPG730/02 Question For people with mild or moderate tricuspid regurgitation, evidence on the safety and efficacy of transcatheter
Recommendation ID IPG731/02 Question For people with mild or moderate tricuspid regurgitation, evidence on the safety and efficacy of transcatheter
Recommendation ID NG69/4 Question Treating an eating disorder in people with a comorbidity:- What is the impact of comorbidities on treatment
For isoniazid-resistant TB, what is the most effective regimen for reducing mortality andmorbidity?
Recommendation ID NG33/3 Question For isoniazid-resistant TB, what is the most effective regimen for reducing mortality andmorbidity?